Evergreen, CO

Starlight Clinical Research

Depressive Disorder

Major Depressive Disorder

Depression

CYB003

Psilocybin

Cybin IRL

condition

allSponsorName

Worldwide Clinical Trials

gender

Male

Female

overallStatus

Recruiting

Not yet recruiting

Active, not recruiting

Enrolling by invitation

Completed

Terminated

Withdrawn

Suspended

Unknown

type

Interventional

Observational

Expanded Access

phase

Early Phase 1

Phase 1

Phase 2

Phase 3

Phase 4

Not Applicable

funderTypes

Industry

Other U.S. Federal agency

All others

ageGroup

Child (birth-17)

Adult (18-64)

Older Adult (65+)

The purpose of this study is to examine the efficacy, safety, and tolerability of CYB003 compared to matching placebo as adjunctive treatment in participants with MDD.

"A Study of a Deuterated Psilocin Analog (CYB003) in Humans With Major Depressive Disorder"

Starlight Clinical Research | Evergreen, CO

Site insights

Work at this site?

Active trials

"A Study of a Deuterated Psilocin Analog (CYB003) in Humans With Major Depressive Disorder" (APPROACH)

Trial sponsors